Activation-inactivation of HIV-1 in the lung

Journal of Biomedical Science

Volumn 5, Issue 1, 1998, Pages 1-10

  Rich, Elizabeth A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Alveolar lymphocytes; Alveolar macrophages; Cigarette smoke; HIV 1; Lung; Surfactant; Tuberculosis

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS CARINII;

EID: 0031921790     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253350     Document Type: Review

References (93)

1. Abbud RA, Finegan CK, Guay LA, Rich EA. Enhanced production of human immunodeficiency virus-1 (HIV-1) by in vitro infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 172:859-863; 1995.
2. Agostini C, Zambello R, Trentin L, Garbisa S, DiCelle PF, Bulian P, Onisto M, Poletti V, Spiga L, Raise E, Foa R, Semenzato G. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am Rev Respir Dis 144:195-201;1991.
3. Agostini C, Trentin L, Zambello R, Semenzato G. HIV-1 and the lung: Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 147:1038-1049;1993.
4. Ansfield MJ, Benson BJ. Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol 125:1093-1098:1980.
5. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant suppresses NFKB activation in human monocytic cells. Am J Respir Cell Mol Biol 14:374-379,1996.
6. Autran B, Sadat-Sowti B, Hadida F, Parrot A, Guillon J-M, Plata F, Mayaud C, Debré P. HIV-specific cytotoxic T lymphocytes against alveolar macrophages: Specificities and down-regulation. Res Virol 142:113-118;1991.
7. Bachurski CJ, Pryhuber GS, Glasser SW, Kelly SF, Whitsett JA. Tumor necrosis factor-α inhibits surfactant protein C gene transcription. J Biol Chem 270:19402-19407;1995.
8. Baughman RP, Corser BC, Strohofer S, Hendricks D. Spontaneous hydrogen peroxide release from alveolar macrophages of some cigarette smokers. J Lab Clin Med 107:233-237; 1986.
9. Boulos R, Halsey NA, Holt E, and the City Soleil/Johns Hopkins University AIDS Project Team. HIV-1 in Haitian women 1982-1988. J Acquir Immune Defic Syndr 3:721-728;1990.
10. Brodsky-Doyle B, Leonard KR, Tanner AJ. Modulation of FcR function by complement: Subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J Immunol 138:1150-1157;1987.
11. Buhl R, Jaffa HA, Holroyd KJ, Brook Z, Rorum JH, Mastrageli A, Wells FB, Kirby M, Saltini C, Crystal RG. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 150:1019-1028;1993.
12. Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, Sanchez WC, Grossman RJ, Gordin FM, Biggar RJ, Goedert JJ. Cigarette smoking: A modifier of human immunodeficiency virus type 1 infection. J Acquir Immune Defic Syndr 4.76-83;1991.
13. Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA 256:2356-2359; 1986.
14. Clarke JR, Taylor IK, Fleming J, Nukuna A, Williamson JD, Mitchell DM. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS 7:555-560;1993.
15. Clarke JR, Williamson JD, Mitchell DM. Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients. J Med Virol 39:196-199;1993.
16. Clarke JR, Gates AJ, Coker RJ, Douglas JA, Williamson JD, Mitchell DM. HIV-1 proviral DNA copy number in blood leukocytes and bronchoalveolar lavage cells of AIDS patients. Clin Exp Immunol 96:182-186;1994.
17. Coates RA, Farewell VT, Raboud J, Read SE, MacFadden DK, Calzavara LM, Johnson JK, Sheperd FA, Fanning MM. Cofactors of progression of acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 132:717-722;1990.
18. Craib KJP, Schecter MT, Montaner JSG, Le TN, Sestk P, Willoughby B, Voigt R, Haley L, O'Shaughnessy MV. The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin Invest Med 15:401-408;1992.
19. Daniele RP, Altose MD, Rowlands DT Jr. Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest 56:986-995;1975.
20. Dean NC, Golden JA, Evans LA, Warnock ML, Addison TE, Hopewell PC, Levy JA. Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. Chest 93:1176-1179;1988.
21. Denis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 151:164-169;1995.
22. Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 116:124-128;1992.
23. Ellner JJ. Regulation of the human immune response during tuberculosis. J Lab Clin Med. 1997, in press.
24. Ezekowitz RAB, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169:185-196;1989.
25. Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 133:73-77;1983.
26. Gartner SP, Markovits DM, Markovitz MH, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219;1986.
27. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J Clin Invest 93: 474-478;1994.
28. Gendelman HE, Narayan O, Kennedy-Stoskopf S, Kennedy PGE, Ghotbi Z, Clements JE, Stanley J, Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: Susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 58:67-74;1986.
29. Goedert JJ, Biggar RJ, Melbye M, Mann DL, Wilson S, Gail MH, Grossman RJ, DiGioia RA, Sanchez WC, Weiss SH, Blattner WA. Effect of T4 and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA 257:331-334; 1987.
30. Goletti D, Weissman D, Jackson RW, Graham NMH, Vlahav D, Klein RS, Munsiff SS, Ortona L, Cauda R, Fauci AS. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 157:1271-1278;1996.
31. Guay LA, Sierra-Madero JG, Finegan CK, Rich EA. Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A. Am J Respir Cell Mol Biol 16: 421-428;1997.
32. Guillon J-M, Autran B, Denis M, Fouret P, Plata F, Maynaud CM, Akoun GM. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 94:1264-1270;1988.
33. Halsey NA, Coberly JS, Holt E, Coreil J, Kissinger P, Moulton LH, Brutus JR, Boulos R. Sexual behavior, smoking and HIV-1 infection in Haitian women. JAMA 267:2062-2066; 1992.
34. Hayakawa H, Giridhar G, Myrvik QN, St.Clair RW. Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 51:379-385;1992.
35. Hocking WG, Golde DW. The pulmonaryalveolar macrophage (first of two parts). N Engl J Med 301:580-587;1979.
36. Hocking WG, Golde DW. The pulmonaryalveolar macrophage (second of two parts). N Engl J Med 301:639-645;1979.
37. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F. Unusually high frequencies of HIV-specific cytotoxic lymphocytes in humans. J Immunol 142:452-462;1984.
38. Hyoidal JR, Fox RB, LeHarbre PA, Takiff HE, Repine JE. Oxidative metabolism of alveolar macrophages from young asymptomatic cigarette smokers: Increased superoxide anion release and its potential consequences. Chest 77: 270-271;1980.
39. Hyoidal JR, Niewoehner DE. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. Am Rev Respir Dis 126:548-552:1982.
40. Israel-Biet D, Cadranel J, Beldjord K, Andrieu J-M, Jeffrey A, Even P. Tumor necrosis factor production in HIV seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 147:490-494;1991.
41. Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 91:11378-11382;1994.
42. Iwamoto GK, Konicek SA, Twigg III HL. Modulation of accessory cell function and interleukin-6 production by the HIV-1 tat gene. Am J Respir Cell Mol Biol 10:578-585;1994.
43. Krishnan VL, Meager A, Mitchell DM, Pinching AJ. Alveolar macrophages in AIDS patients: Increased spontaneous tumor necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol 80:156-160:1990.
44. Landay AL, Schade SZ, Takefman DM, Kuhns MC, McNamara AL, Rosen RL, Kessler HA, Spear GT. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J Acquir Immune Defic Syndr 6:171-175;1993.
45. Lapenna E, De Gioia S, Mezzetti A, Ciofani G, Consoli A, Marzio X, Cuccurullo F. Cigarette smoke, ferntin, and lipid peroxidation. J Respir Crit Care Med 151:431-435;1995.
46. Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 153:799-804; 1996.
47. Lebargy F, Branellec A, Deforges L, Bignon J, Bemaudin J-F. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 10:72-78;1994.
48. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam C-Z, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 7: 727-733;1994.
49. Martin RR. Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis 107:596-601;1973.
50. Nakata K, Weiden M, Harkin T, Ho D, Rom WN. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: Evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 7:744-757; 1995.
51. Nakata K, Rom WM, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 155:996-1003;1997.
52. Narayan O, Kennedy-Stoskopf S, Sheffer D, Griffin DE, Clements JE. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 41:67-73;1983.
53. Newell GR, Mansell PWA, Wilson MB, Lynch HK, Spitz MR, Hersh EM. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev Med 14:81-89;1985.
54. Nieman RB, Fleming J, Coker RJ, Harris JRW, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 7:705-710; 1993.
55. Ogawa T, Uchida H, Hahada J. Increase in TNFα and IL-6 secreting cells in PBMC from subjects infected with Mycobacterium tuberculosis. Infect Immun 59:3021-3025;1991.
56. Ognibene FP, Masur H, Rogers P, Travis WD, Suffredini AF, Feurerstein I, Gill VJ, Baird BF, Carraquillo JA, Parrillo JE, Lane HC, Shelhammer JH. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus. Ann Intern Med 109: 874-879;1988.
57. Pacht ER, Kaseki H, Mohammed JR, Cornwell DG, Davis WB. Deficiency of vitamin E in the alveolar fluid of cigarette smokers: Influence on alveolar macrophage cytotoxicity. J Clin Invest 77:789-796;1986.
58. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327-335; 1993.
59. Pape JW, Jean SS, Ho JL, Hafner A, Johnson DW Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342:268-272;1993.
60. Phelps DS, Rose RM. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am Rev Respir Dis 143:1072-1075;1991.
61. Plata F, Autran B, Martins LP, Wain-Hobson S. Raphaël M, Mayaud C, Denis M, Guillon J-M, Debré P. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328: 348-351:1987.
62. Plata F, Garcia-Pons F, Ryter A, Lebargy F, Goodenow M, Quan Dat MH, Autran B, Mayaud C. HIV-1 infection of lung alveolar fibroblasts and macrophages in humans. AIDS Res Hum Retroviruses 6:979-985;1990.
63. Potash MJ, Ziera M, Huang Z-B, Pearce TE, Eden E, Gendelman HE, Volsky DJ. Virus-cell membrane fusion does not predict efficient infection of alveolar macrophages by human immunodeficiency virus type I (HFV-1). Virology 188:864-868;1992.
64. Pryhuber GS, Bachurski C, Rirsch R, Bacon A, Whitsett JA. Tumor necrosis factor-a decreases surfactant protein B mRNA in murine lung. Am J Physiol 270:1714-721;1996.
65. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 136:258-265;1987.
66. Rich EA, Panuska JR, Wallis RS, Wolf CB, Leonard ML, Ellner JJ. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 139:1010-1016;1989.
67. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89:176-183; 1992.
68. Rich EA, Abbud RA. Iron and oxidative stress in smokers' alveolar macrophages: Effects on HIV load in the lung? J Infect Dis 173:1046-1047;1996.
69. Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis 143:850-854;1991.
70. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68:281-284;1986.
71. Schauble TL, Boom WH, Finegan CK, Rich EA. Characterization of suppressor function of human alveolar macrophages for T lymphocytes responses to phytohemagglutinin: Cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell 8:89-97; 1993
72. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauce AS. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4, Science 245: 305-308;1989.
73. Schuitemaker H, Koot M, Koostra NA, Dercksen MW, DeGoede REY, van Steenwijk RP, Lange JMA, Schattenkerk JKME, Miedema F, Tersmene M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 66:1354-1360;1992.
74. Schwander SK, Sada-Diaz E, Torres M, Escobedo-Sanchez D, Sierra-Madero JG, Alt S, Rich EA. T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis 173:1267-1272;1996.
75. Semenzato G, Agostini C, Ometto L, Zambello R, Trentin L, Chieco-Bianchi L, de Rossi A. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 85:2308-2314;1995.
76. Sherman MP, Campbell LA, Gong Jr H, Roth MD, Tashkin DP. Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am Rev Respir Dis 144:1351-1358;1991.
77. Sierra-Madero J, Toossi Z, Hom DL, Finegan CK, Hoenig E, Rich EA. Relationship between load of virus in alveolar macrophages of human immunodeficiency virus-infected persons, production of cytokines and clinical status. J Infect Dis 169:18-27;1994.
78. Sternberg RI, Whitsett JA, Hill WM, Baughman RP. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J Lab Clin Med 125:462-469; 1995.
79. Stover DE, White DA, Romano PA, Gellene RA, Robeson WA. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med 78:429-437; 1985.
80. Takashima T, Keta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor-α by monocytes from patients with pulmonary tuberculosis. Infect Immun 58:3286-3292;1990.
81. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am J Respir Cell Mol Biol 10: 399-404;1994.
82. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus-1. J Exp Med 177:1511-1516;1993.
83. Toossi Z, Hirsch CS, Hamilton BD, Finegan CK, Friedlander MA, Rich EA. Decreased production of transforming growth factor β1 (TGFβ1) in human alveolar macrophages compared to blood monocytes. J Immunol 156: 3461-3468;1996.
84. Toossi Z, Hamilton BD, Phillips MH, Averill LE, Ellner J, Salvekar A. Regulation of nuclear factor-κB and its inhibitor IκB-α-MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J Immunol 159: 4109-4116;1997.
85. Toossi Z, Nicolacakis K, Xin L, Ferrari NA, Rich EA. Activation of latent human immunodeficiency virus-1 (HIV-1) by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J AIDS, 1997, in press.
86. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, di Francesco C, Cipriani A, Francavilla E, Semenzato G. Spontaneous production of IL-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 166:731-737;1992.
87. Twigg HL, Lipscomb MF, Yaffe B, Barbara DJ, Weissler JC. Enhanced accessory cell function by alveolar macrophages from patients infected with human immunodeficiency virus and its potential role for depletion of CD4+ cells in the lung. Am J Respir Cell Mol Biol 1: 391-400;1989.
88. Vanham G, Edmonds K, Qing L, Horn D, Toossi Z, Jones B, Daley CL, Huebner R, Kestens L, Gigase P, Ellner JJ. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV-infection. Clin Exp Immunol 102:30-34;1996.
89. Wallace JM, Rao AV, Glassroth J, Hansen NI, Rosen MJ, Arakaki C, Kvale PA, Reichman LB, Hopewell PC and the Pulmonary Complications of HIV Infection Study Group. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 148:1523-1529;1993.
90. Whalen C, Horsburgh CR, Horn D, Lahart C Simberkoff M, Ellner JJ. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 151: 129-135;1995.
91. White DA, Matthay RA. Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis 140:1763-1787;1989.
92. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222;1990.
93. Zhang Y, Nakata K, Weiden M, Rom WN. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 95:2324-2331;1995.